Rtw Investments, LP Adverum Biotechnologies, Inc. Transaction History

Rtw Investments, LP

$6.27 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $181,217 - $299,791	-223,725 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $9.02 Million - $14.3 Million	-7,331,092 Reduced 97.04%	223,725 $293,000
Q4 2021 Feb 14, 2022	BUY	$1.74 - $2.4 $123,644 - $170,544	71,060 Added 0.95%	7,554,817 $13.3 Million
Q3 2021 Nov 15, 2021	BUY	$2.08 - $3.6 $261,747 - $453,024	125,840 Added 1.71%	7,483,757 $16.2 Million
Q2 2021 Aug 13, 2021	BUY	$3.36 - $10.56 $30,041 - $94,416	8,941 Added 0.12%	7,357,917 $25.8 Million
Q1 2021 May 14, 2021	BUY	$9.26 - $14.36 $1.13 Million - $1.75 Million	121,612 Added 1.68%	7,348,976 $72.5 Million
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $72,816 - $105,524	-7,400 Reduced 0.1%	7,227,364 $78.3 Million
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $4.58 Million - $9.62 Million	444,737 Added 6.55%	7,234,764 $74.5 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $1.35 Million - $4.06 Million	158,400 Added 2.39%	6,790,027 $142 Million
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $1.96 Million - $4 Million	245,020 Added 3.84%	6,631,627 $64.8 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $540,692 - $1.29 Million	105,604 Added 1.68%	6,386,607 $73.6 Million
Q3 2019 Nov 14, 2019	SELL	$5.24 - $15.89 $206,178 - $625,223	-39,347 Reduced 0.62%	6,281,003 $34.2 Million
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $323,901 - $755,133	63,510 Added 1.02%	6,320,350 $75.1 Million
Q4 2018 Feb 14, 2019	BUY	$2.87 - $5.92 $17.4 Million - $35.9 Million	6,072,019 Added 3285.35%	6,256,840 $19.7 Million
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $38,020 - $64,212	8,449 Added 4.79%	184,821 $1.12 Million
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $6,169 - $8,031	1,164 Added 0.66%	176,372 $935,000
Q1 2018 May 14, 2018	BUY	$3.65 - $7.95 $639,509 - $1.39 Million	175,208 New	175,208 $1.02 Million

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account